Experts Discuss How NGS Of Tumor Tissue And cfDNA Analysis Of Blood Samples Can Identify Potentially Actionable Targets In Patients With Cancer Of Unknown Primary

Medscape (6/11, Davenport, Subscription Publication) reports, “Next-generation sequencing (NGS) of tumor tissue and cell-free DNA (cfDNA) analysis of blood samples are identifying potentially actionable targets in patients with cancer of unknown primary (...